Literature DB >> 21774672

Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.

Annalene M Nel1, Lynne B Mitchnick, Peter Risha, Lungwani Tyson Makoye Muungo, Pamela M Norick.   

Abstract

BACKGROUND: Vaginal microbicides are in development for the prevention of HIV transmission to women via sexual intercourse. Acceptability of the microbicide delivery method in the targeted population is important to product adherence and, therefore, product effectiveness. It is anticipated that multiple delivery methods will be required to satisfy personal preferences among future microbicide users.
METHODS: A total of 526 sexually active women aged 18-30 years participated in a consumer product preference study in Burkina Faso, Tanzania, and Zambia. Screened women who had given consent were instructed to use each of the three products (placebo formulations of a vaginal tablet, film, and soft-gel capsule) once daily for 7 consecutive days for a total of 21 days. Women were interviewed about their impressions of the product at the completion of each 7-day trial period.
RESULTS: Over 80% of women reported they liked using each dosage form, and over 85% said they would definitely use it. The film and soft-gel capsule were chosen significantly more often than the tablet as the preferred dosage form (39% and 37% vs. 25%, respectively) mainly because of faster dissolving time and easier insertion. Women in Burkina Faso and Tanzania preferred the soft-gel capsule (42%-46%), whereas Zambian women preferred the film (51%). Age, socioeconomic status, and marital status did not significantly affect product preference.
CONCLUSIONS: All three dosage forms were acceptable to the women surveyed. Preferred dosage forms varied by country. These data suggest that the availability of microbicides in multiple dosage forms may increase acceptability, adherence, and, therefore, effectiveness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21774672     DOI: 10.1089/jwh.2010.2476

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  31 in total

1.  Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results.

Authors:  Elizabeth T Montgomery; Jonathan Stadler; Sarita Naidoo; Ariana W K Katz; Nicole Laborde; Morgan Garcia; Krishnaveni Reddy; Leila E Mansoor; Juliane Etima; Chifundo Zimba; Miria Chitukuta; Lydia Soto-Torres
Journal:  AIDS       Date:  2018-07-17       Impact factor: 4.177

2.  Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.

Authors:  Toral Zaveri; Cordelia A Running; Lahari Surapaneni; Gregory R Ziegler; John E Hayes
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

3.  Acceptability and use of a dapivirine vaginal ring in a phase III trial.

Authors:  Elizabeth T Montgomery; Ariane van der Straten; Miria Chitukuta; Krishnaveni Reddy; Kubashni Woeber; Millicent Atujuna; Linda-Gail Bekker; Juliane Etima; Teopista Nakyanzi; Ashley J Mayo; Ariana Katz; Nicole Laborde; Cynthia I Grossman; Lydia Soto-Torres; Thesla Palanee-Phillips; Jared M Baeten
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

Review 4.  Methodological lessons from clinical trials and the future of microbicide research.

Authors:  Ariane van der Straten; Elizabeth T Montgomery; Miriam Hartmann; Alexandra Minnis
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

5.  Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05).

Authors:  Jennifer A Robinson; Mark A Marzinke; Edward J Fuchs; Rahul P Bakshi; Hans M L Spiegel; Jenell S Coleman; Lisa C Rohan; Craig W Hendrix
Journal:  J Acquir Immune Defic Syndr       Date:  2018-02-01       Impact factor: 3.731

6.  Electrospun solid dispersions of Maraviroc for rapid intravaginal preexposure prophylaxis of HIV.

Authors:  Cameron Ball; Kim A Woodrow
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

7.  The Role of Volume in the Perceptibility of Topical Vaginal Formulations: User Sensory Perceptions and Experiences of Heterosexual Couples During Vaginal Sex.

Authors:  Kate M Guthrie; Joseph L Fava; Sara E Vargas; Rochelle K Rosen; Julia G Shaw; Erna M Kojic; Anthony S Ham; Lisa C Rohan; David Katz; Anacecilia Panameño; Christopher Colleran; David F Friend; Karen W Buckheit; Robert W Buckheit
Journal:  AIDS Res Hum Retroviruses       Date:  2020-11-03       Impact factor: 2.205

Review 8.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

9.  Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women.

Authors:  Maria D Fan; Lindsay F Kramzer; Sharon L Hillier; Judy C Chang; Leslie A Meyn; Lisa C Rohan
Journal:  Arch Sex Behav       Date:  2016-08-29

10.  Safety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis.

Authors:  Priya Srinivasan; Jining Zhang; Amy Martin; Kristin Kelley; Janet M McNicholl; Robert W Buckheit; James M Smith; Anthony S Ham
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.